Remedy Robotics

Remedy Robotics is a healthcare company in San Francisco, United States, founded in 2020. It has raised $85.0M across 2 rounds, most recently a $50.0M Series B in October 2025.

Remotely operated endovascular robots delivering specialist care everywhere

Employees
11–50
Founded
2020
Business Model
B2B
Total Funding
$85.0M
Last Round
$50.0M Series BOct 2025
Rounds
2

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 2 funding rounds and 2 investors for this company. The full record is or through the API.

About

Remedy Robotics is a San Francisco-based surgical robotics company developing the world's first remotely operated endovascular robotic system. Founded in 2020 by David Bell (CEO, cardiac surgeon) and Jake Sganga, the company's mission is to deliver immediate, high-quality endovascular intervention to any patient regardless of geographic location or hospital resources. The system enables trained interventionalists to perform complex endovascular procedures — including stroke and cardiovascular interventions — from a remote console, eliminating the need for specialist on-site presence. Remedy achieved multiple world firsts: fully robotic neurointerventional procedures in humans (November 2024) and the first remote neurointerventional procedures with the clinician in a separate hospital from the patient (September 2025). The company is preparing for its pivotal clinical trial and has partnered with hospitals and research institutions globally.

Summary

It lists 11–50 employees. It has raised $85.0M in total across 2 rounds, most recently a $50.0M Series B round in Oct 2025. Investors include DCVC (Data Collab) and Blackbird Ventures.

Tech & App Stack

5 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Data from Indexed.vcUpdated
Series BSeries BOct 2025
$50.0M

Sign up to see all 2 events

Funding: Series A through Series B. Amounts, valuations, and investors where available.

Investors

Similar Companies

MultiPlanIPO

Healthcare cost management company providing data analytics and network-based payment solutions t...

New York, United States1001–5000Healthcare
Private EquityTotal funding$7.4BMar 2014
The Bountiful CompanyAcquired

American dietary supplements company owning Nature's Bounty, Solgar, and Puritan's Pride brands; ...

Ronkonkoma, United States1001–5000Healthcare, Retail
Private EquityTotal funding$7.0BJul 2017
Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
OneOncologyAcquired

OneOncology empowers oncology practices with advanced tools and capabilities to help physicians d...

Nashville, United States1001–5000Healthcare, Data & Analytics
Extension RoundTotal funding$5.1BDec 2025
Canopy Growth Corporation Common SharesIPO

World-leading Canadian cannabis company cultivating and selling medicinal and recreational cannab...

Smiths Falls, Canada1001–5000Healthcare
Corporate RoundTotal funding$4.5BJan 2024
Inizio

Inizio helps health and life sciences clients realize product potential through deep expertise, g...

New York, United States10001+Healthcare
Venture RoundTotal funding$4.4B

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Remedy Robotics on Indexed.vc
<a href="https://indexed.vc/companies/remedy-robotics"><img src="https://indexed.vc/api/badge/company/remedy-robotics" alt="Remedy Robotics on Indexed.vc" width="260" height="76" /></a>